Evidence map›Paper›PMID 23053712›Full record

ReviewMagma (New York, N.Y.)2013

PET-MR imaging using a tri-modality PET/CT-MR system with a dedicated shuttle in clinical routine.

Patrick Veit-Haibach, Felix Pierre Kuhn, Florian Wiesinger, Gaspar Delso, Gustav von Schulthess

Abstract readReview
PubMed Publisher
In one paragraph

Review in Magma (New York, N.Y.), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. International EANM-SNMMI-ISMRM consensus recommendation for PET/MRI in oncology.European journal of nuclear medicine and molecular imaging · 2023
    Article
  5. SPECT/CT and PET/CT, related radiopharmaceuticals, and areas of application and comparison.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2023
    Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. European journal of hybrid imaging · 2018
    Article
  11. PET/MRI: a frontier in era of complementary hybrid imaging.European journal of hybrid imaging · 2018
    Review
  12. Article
  13. Article
  14. Biomedical optics express · 2017
    Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Patrick Veit-HaibachDepartment of Medical Imaging, University Hospital, Rämistrasse 100, 8091 Zurich, Switzerland. patrick.veit-haibach@usz.ch
Felix Pierre Kuhn
Florian Wiesinger
Gaspar Delso
Gustav von Schulthess

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tri-modality PET/CT-MRI includes the transfer of the patient on a dedicated shuttle from one system into the other. Advantages of this system include a true CT-based attenuation correction, reliable PET-quantification and higher flexibility in patient throughput on both systems. Comparative studies of PET/MRI versus PET/CT are readily accomplished without repeated PET with a different PET scanner at a different time point. Additionally, there is a higher imaging flexibility based on the availability of three imaging modalities, which can be combined for the characterization of the disease. The downside is a somewhat higher radiation dose of up to 3 mSv with a low dose CT based on the CT-component, longer acquisition times and potential misalignment between the imaging components. Overall, the tri-modality PET/CT-MR system offers comparative studies using the three different imaging modalities in the same patient virtually at the same time, and may help to develop reliable attenuation algorithms at the same time.

Indexed as

Equipment DesignHumansMagnetic Resonance ImagingPositron-Emission TomographyTomography, X-Ray Computed

Identifiers

PMID23053712

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.